Engineered probiotics can detect tumors in the liver: press for recent STM publication

May 28, 2015

The May 27, 2015 issue of Science Translational Medicine features an article from the lab which develops programmable probiotics capable of detecting small cancer metastases in the liver, creating a signal that is detectable in the urine (Danino et al 2015).


See in depth coverage from MIT News and The Scientist, as well as features in: